Psilocybin therapy for methamphetamine use and HIV
Treatments studied
Part of Immune system & allergy, Infections, Mental health clinical trials.
This trial tests whether psilocybin (a psychedelic medicine) can help people who use methamphetamine and are living with HIV reduce or stop their meth use. You would receive psilocybin in a supervised setting and get counseling support to help you reach your goal of quitting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 64 years old
- You have been living with HIV for at least 3 months
- You have moderate-to-severe methamphetamine use disorder and want to quit
- You can live somewhere stable and avoid meth and other non-prescribed drugs for 24 hours before and during the psilocybin sessions
- You have a working cellphone and are willing to use effective birth control (if applicable)
- You can speak and understand English well enough for study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psilocybin, a psychedelic substance, can help people with moderate to severe methamphetamine use disorder reduce or stop their use. It may work by helping the brain reset, but it's not a standard treatment and involves careful monitoring.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
This study looks at how a single dose of methamphetamine affects the hidden HIV that stays in the body even when the virus is undetectable. It may help researchers understand how to better treat or cure HIV in the future.
This study tests whether a psychedelic drug called psilocybin, combined with talk therapy, can help people reduce or stop their use of stimulants like methamphetamine. It aims to see if this treatment is safe and helpful.
This study tests whether a medicine called psilocybin, combined with talk therapy, can help people with hard-to-treat depression and a substance use problem. It aims to see if this treatment can improve mood and reduce substance use.
This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.
Hear when a new Methamphetamine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.